Skip to content

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03769207
Enrollment
17
Registered
2018-12-07
Start date
2018-12-08
Completion date
2019-08-20
Last updated
2020-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter

Brief summary

This post-marketing study is conducted to characterize the ability of Apple Watch rhythm analysis software to identify Atrial Fibrillation (AF) and facilitate subsequent clinical evaluation among users who contact AppleCare.

Interventions

Eligible participants are asked to wear the ambulatory ECG monitor

Sponsors

Apple Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Possession of the following at time of eligibility screening: * iPhone (5s or later) with iOS version 12.1.1 or later defined as iPhone model/iOS version used to complete screening eligibility. * Apple Watch (Series 1-4) with watchOS version 5.1.2 or later defined as Apple Watch model/watchOS paired with iPhone used to complete screening eligibility 2. At least one of the following by self-report before consent: * Irregular Rhythm Notification * ECG app classification of Atrial Fibrillation * ECG app classification of Inconclusive defined as Inconclusive, Heart Rate Over 120, or Heart Rate Under 50 3. Age ≥ 22 years at time of eligibility screening 4. Current resident of the United States at time of eligibility screening, and will reside in the United States for the length of the study 5. Proficient in written and spoken English 6. Valid phone number associated with iPhone, ascertained from self-report 7. Valid email address, ascertained from self-report

Exclusion criteria

1. Shared iCloud account 2. Shared AppleWatch

Design outcomes

Primary

MeasureTime frameDescription
Atrial Fibrillation or Atrial Flutter (AF) of at Least 30 Seconds DurationDuring ambulatory ECG Monitoring (up to 8 days)Detected on ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification

Secondary

MeasureTime frameDescription
Arrhythmias Other Than AFDuring ambulatory ECG Monitoring (up to 8 days)Detected on an ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification
Self-reported Contact With Healthcare ProviderBetween 15 to 90 days following enrollment

Countries

United States

Participant flow

Recruitment details

Participants who received an irregular pulse notification or who had an AF classification on the ECG app and then called the sponsor's customer support were invited to download the study app and enroll. They had a remote study visit, were sent an ECG patch to wear and return for analysis, and had a second remote visit to review the findings.

Participants by arm

ArmCount
Ambulatory ECG
Ambulatory ECG: Eligible participants are asked to wear the ambulatory ECG monitor
17
Total17

Baseline characteristics

CharacteristicAmbulatory ECG
Age, Continuous52.4 years
STANDARD_DEVIATION 16.1
Race/Ethnicity, Customized
Asian
1 Participants
Race/Ethnicity, Customized
Middle Eeastern or North African
1 Participants
Race/Ethnicity, Customized
Preferred not to respond
1 Participants
Race/Ethnicity, Customized
White
14 Participants
Region of Enrollment
United States
17 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
13 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 17
other
Total, other adverse events
4 / 17
serious
Total, serious adverse events
0 / 17

Outcome results

Primary

Atrial Fibrillation or Atrial Flutter (AF) of at Least 30 Seconds Duration

Detected on ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification

Time frame: During ambulatory ECG Monitoring (up to 8 days)

ArmMeasureValue (NUMBER)
Ambulatory ECGAtrial Fibrillation or Atrial Flutter (AF) of at Least 30 Seconds Duration0.11 Proportion of participants
Secondary

Arrhythmias Other Than AF

Detected on an ambulatory ECG patch monitor for a participant who received an IRN or Apple Watch ECG app - AFib classification

Time frame: During ambulatory ECG Monitoring (up to 8 days)

ArmMeasureValue (NUMBER)
Ambulatory ECGArrhythmias Other Than AF0 Proportion of participants
Secondary

Self-reported Contact With Healthcare Provider

Time frame: Between 15 to 90 days following enrollment

ArmMeasureValue (NUMBER)
Ambulatory ECGSelf-reported Contact With Healthcare Provider0.56 Proportion of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026